Abstract
Gemini surfactant-lipid cationic nanoparticles (NP) and electroporation (EP) with a novel tape-electrode were evaluated in mice as topical delivery methods for plasmid DNA encoding luciferase reporter gene or interferon gamma (IFNg). NP treatment of the skin without EP (dose: 25 microgram plasmid DNA/50 microliter formulation) enhanced skin expression of IFNg, three-fold compared to buffer control or topical plasmid solution, whereas application of the noninvasive tape-probe to deliver the electroporative effect after topical NP treatment decreased gene expression compared with topical NP treatment alone. Gemini NPs are a potential topical gene delivery system, however subsequent use of EP showed an inhibitory effect.
Keywords: Electroporation, gene therapy, nanoparticles, non-viral, plasmid, skin, topical, Gemini surfactant-lipid cationic nanoparticles, NP treatment
Drug Delivery Letters
Title: Topical Gene Delivery in Mice Using Gemini Surfactant - Lipid Nanoparticles With and Without Tape Electrode Electroporation
Volume: 1 Issue: 1
Author(s): I. Badea, N. Shaterian and M. Foldvari
Affiliation:
Keywords: Electroporation, gene therapy, nanoparticles, non-viral, plasmid, skin, topical, Gemini surfactant-lipid cationic nanoparticles, NP treatment
Abstract: Gemini surfactant-lipid cationic nanoparticles (NP) and electroporation (EP) with a novel tape-electrode were evaluated in mice as topical delivery methods for plasmid DNA encoding luciferase reporter gene or interferon gamma (IFNg). NP treatment of the skin without EP (dose: 25 microgram plasmid DNA/50 microliter formulation) enhanced skin expression of IFNg, three-fold compared to buffer control or topical plasmid solution, whereas application of the noninvasive tape-probe to deliver the electroporative effect after topical NP treatment decreased gene expression compared with topical NP treatment alone. Gemini NPs are a potential topical gene delivery system, however subsequent use of EP showed an inhibitory effect.
Export Options
About this article
Cite this article as:
Badea I., Shaterian N. and Foldvari M., Topical Gene Delivery in Mice Using Gemini Surfactant - Lipid Nanoparticles With and Without Tape Electrode Electroporation, Drug Delivery Letters 2011; 1 (1) . https://dx.doi.org/10.2174/2210304x11101010062
DOI https://dx.doi.org/10.2174/2210304x11101010062 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Minocycline and Doxycycline: More Than Antibiotics
Current Molecular Pharmacology Molecular Targeting of Cell Death Signal Transduction Pathways in Cancer
Current Signal Transduction Therapy Oligomerization of G Protein-Coupled Receptors: Biochemical and Biophysical Methods
Current Medicinal Chemistry Antiviral Activity of Phytochemicals: A Comprehensive Review
Mini-Reviews in Medicinal Chemistry Endothelin and the Ischaemic Heart
Current Vascular Pharmacology Immune-Inflammation in Atherosclerosis: A New Twist in an Old Tale
Endocrine, Metabolic & Immune Disorders - Drug Targets Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy
Current Genomics Statin-induced Vascular Smooth Muscle Cell Apoptosis: A Possible Role in the Prevention of Restenosis?
Current Drug Targets - Cardiovascular & Hematological Disorders Retinal Imaging: A New Tool for Studying Underlying Liability to Cardiovascular Disease in Schizophrenia
Current Psychiatry Reviews Inactivation of Parathyroid Hormone: Perspectives of Drug Discovery to Combating Hyperparathyroidism
Current Molecular Pharmacology Targeting ATP7A to Increase the Sensitivity of Neuroblastoma Cells to Retinoid Therapy
Current Cancer Drug Targets Acute <i>Versus</i> Chronic Administration of Calcineurin-Inhibitors Differentially Affect T-Cell Function
Endocrine, Metabolic & Immune Disorders - Drug Targets Muscle Atrophy Classification: The Need for a Pathway-Driven Approach
Current Pharmaceutical Design Cardiovascular Disease and Dyslipidemia: Beyond LDL
Current Pharmaceutical Design Photothermal Ablation of Cancer Cells Using Folate-Coated Gold/ Graphene Oxide Composite
Current Drug Delivery The Molecular Concept of Atheromatous Plaques
Current Drug Targets Biomarker Diversity, Validation and Clinical Translation: Tenets for Emergent Personalized Medicine Initiatives
Current Pharmacogenomics and Personalized Medicine Potential Application of Gene Therapy to X-Linked Agammaglobulinemia
Current Gene Therapy Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
Current Pharmaceutical Design Modulation of GABAA Receptors in the Treatment of Epilepsy
Current Pharmaceutical Design